Hôpital Foch

Verified siteinfo

France 40 Rue Worth, 92151, 92151 Suresnes, France

4 trials recruiting
Bronchopulmonary aspergillosis · Ischaemic stroke · Non-small cell lung cancer
Adult patients

About Specializations

Hôpital Foch in Suresnes, France specialises in clinical trials of conditions such as Bronchopulmonary aspergillosis, Ischaemic stroke, Non-small cell lung cancer, Tumour of ampulla of Vater, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Diseases

The research team at Hôpital Foch is evaluating new post‑surgical strategies for ampullary adenocarcinoma, aiming to increase the proportion of patients who remain cancer‑free two years after operation.

Adjuvant chemotherapy after surgical resection
Modified FOLFIRINOX regimen versus standard agents
Improving two‑year disease‑free survival rates

This work reflects the site’s commitment to advancing treatment options for rare gastrointestinal tumors.

Neoplasms

A pivotal study at Hôpital Foch investigates a novel combination of LY3537982 with pembrolizumab for patients whose KRAS G12C‑mutant non‑small cell lung cancer is advanced, seeking to define the most effective first‑line regimen.

First‑line targeted therapy for KRAS‑mutated lung cancer
Combination with immunotherapy to boost response
Dose‑optimization to balance efficacy and safety

The trial highlights the centre’s focus on precision oncology and collaborative drug development.

Circulatory and Respiratory Physiological Phenomena

Two parallel programs at Hôpital Foch address critical lung and vascular conditions: one examines intravenous thrombolysis in patients with acute ischemic stroke who have recently taken direct oral anticoagulants, while the other compares antifungal strategies—including itraconazole plus nebulised Ambisome®—for chronic pulmonary aspergillosis.

Evaluating IV thrombolysis safety in anticoagulated stroke patients
Optimizing antifungal regimens for chronic lung infection
Measuring clinical and radiological outcomes across both studies

These investigations illustrate the department’s dedication to improving outcomes in both vascular emergencies and persistent respiratory infections.

Miscellaneous Research

Beyond disease‑specific projects, Hôpital Foch conducts a suite of clinical trials that integrate multidisciplinary expertise, rigorous safety oversight, and patient‑focused design across four therapeutic domains.